Dexacort Powder (Dexamethasone 10mg Sachet)

This treatment applies to the following species:

  • Beef Cattle
  • Dairy Cattle
  • Horses
  • Veal

Manufacturer: Rafter 8

Dexamethasone powder
DIN 02349264
For Veterinary Use Only

Active ingredient (per 15 g sachet): 10 mg dexamethasone

Dexacort Powder Indications

For the treatment of arthritis and in"ammatory conditions involving the joints and accessory structures in cattle and horses. For supportive therapy in pneumonia, rhinitis and other respiratory conditions, osteoarthritic lameness and various stress conditions in cattle and horses such as ketosis and metritis, dystocia, and retained placenta (cattle) and traumatic injuries to the appendicular skeleton (horses).

Dexacort Powder Dosage And Administration

Administer by drench or by sprinkling on a small amount of feed. The dosage of Dexacort Powder must be individualized according to the severity of the condition, anticipated duration of therapy, tolerance to the steroid and the response obtained. Treatment may be changed to Dexacort Powder from any of the older corticosteroids with the proper reduction of dosage. Recommended dosages should not be exceeded.

  • Cattle: 5 to 10 mg on 1st day, then 5 mg daily as required.
  • Horses: 5 to 10 mg daily in single or divided doses until a clinical response is noted.

If a response to Dexacort Powder is not achieved in 5 days, the possibility should be considered that the condition under treatment is not amenable to corticosteroid therapy and other therapy should be initiated. The use of oral dexamethasone is supportive therapy in animals with acute or chronic bacterial infections and does not eliminate the need to employ speci!c antibiotic or chemotherapeutic agents to combat the primary condition. All corticosteroids may mask signs of infection, therefore, if questionable !ndings occur, temporarily discontinue therapy with this product until a de!nite diagnosis is made.

Dexacort Powder Cautions

Because Dexacort Powder is an extremely potent drug with profound physiological e#ects, all precautions and contraindications for adrenocortical hormones must be observed. The warning signs of cortisone overdosage may not be present with dexamethasone therapy. In certain cases where large doses are required, the patient must be closely observed for side e#ects such as polyuria and polydipsia. When side e#ects occur, it may be necessary to reduce the dosage or to discontinue therapy. Continuous large doses of Dexacort Powder may result in some depression of adrenocortical function and may produce adrenal atrophy. Rest periods and stimulation of adrenocortical function with ACTH may be advisable. If long-term Dexacort Powder therapy is to be terminated, gradual withdrawal is recommended. Should the animal subsequently be subjected to shock or undue stress, temporary therapy with dexamethasone is recommended. The possible action of Dexacort Powder in delaying wound healing also should be considered.


Keep out of reach of children.


Store at room temperature (15-30°C). Keep from freezing.


Carton of 30 x 15 g sachets.